Gyre Therapeutics, Inc. GYRE Gyre — Operating Expenses

Other segment segments

Similar metrics at other companies

DBVTExpenses by function — Operating Expenses

$14M+79.5%

NAVIAll Other Segments — Operating Expenses

$34M-35.8%

PRMEReportable Segment — Operating Expenses

$51.51M-4.3%

WDCorporate — Operating Expenses

$49.09M+26.1%

ARESOther — Operating Expenses

$838.5K+235%

CRONReportable Segment — Operating Expenses

$20.99M+17.9%

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre — operating expenses?

Gyre Therapeutics, Inc. (GYRE) reported gyre — operating expenses of $6.28M in Q1 2026.

How has Gyre Therapeutics, Inc.'s gyre — operating expenses changed year-over-year?

Gyre Therapeutics, Inc.'s gyre — operating expenses increased by 329.7% year-over-year, from $1.46M to $6.28M.

What is the long-term trend for Gyre Therapeutics, Inc.'s gyre — operating expenses?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre — operating expenses has grown at a -69.0% compound annual growth rate (CAGR), from $88.4M to $8.49M.

What does gyre — operating expenses mean?

This is the aggregate of all costs incurred by the segment to conduct its day-to-day business operations, excluding the cost of goods sold. It encompasses research and development, selling and marketing, and general and administrative expenses. It serves as a primary measure of the segment's total operational burn rate.